Filana Therapeutics Inc.
FLNA | NASDAQ
$0.59
-$0.03 (-5.14%)
Nov 2, 2026, 11:42 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 82.68M | 86.57M | 95.5M | 106.08M | 112.38M | 117.33M | 128.57M | 148.98M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | 117K | 120K | 817K | 835K | 864K | 947K | 6.28M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.03M | 1.02M | 1.59M | 107K | 134K | 162K | 38K | 40.19M |
Total Current Assets | 83.72M | 87.96M | 97.71M | 108.91M | 114.82M | 120.15M | 136.53M | 202.55M |
Property-Plant & Equipment | 20.18M | 20.4M | 20.65M | 20.82M | 20.56M | 20.78M | 20.96M | 21.14M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 37K | 69K |
Total Long-Term Assets | 20.18M | 20.4M | 20.65M | 20.82M | 20.56M | 20.78M | 21M | 21.2M |
Total Assets | 103.9M | 108.37M | 118.36M | 129.73M | 135.38M | 140.93M | 157.53M | 223.75M |
Account Payables | 39.29M | 39.19M | 6.4M | 46.09M | 42.82M | 8.19M | 7.65M | 52.24M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 482K | 680K | 35.81M | 588K | 722K | 968K | 1.66M | 2.25M |
Total Current Liabilities | 40.16M | 40.12M | 43.83M | 48.05M | 47.33M | 13.24M | 11.75M | 57.03M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 136K | 111K | 118K | 119K | 79K | 79K | 79K | 80K |
Total Long-Term Liabilities | 136K | 111K | 118K | 119K | 79K | 79K | 79K | 80K |
Total Liabilities | 40.29M | 40.23M | 43.95M | 48.17M | 47.41M | 13.32M | 11.83M | 57.11M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | 63.61M | 68.14M | 74.4M | 81.57M | 87.97M | 127.62M | 145.7M | 166.64M |
Book Value Per Share | 1.32 | 1.41 | 1.54 | 1.69 | 1.82 | 2.64 | 0.03 | 3.47 |
Common Stock | 48K | 48K | 48K | 48K | 48K | 48K | 48K | 48K |
Retained Earnings | -515.02M | -506.42M | -496.08M | -483.55M | -472.74M | -428.51M | -405.11M | -377.51M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 63.61M | 68.14M | 74.4M | 81.57M | 87.97M | 127.62M | 145.7M | 166.64M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove FLNA